Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-May-24 4:05 PM View:  | Akebia Therapeutics, Inc. (AKBA) | 13-May-24 | Sale (Planned) | 12,016 | $1.26 | $15,140.20 | (2%) 663.26K to 651.24K | |
| 01-Mar-24 5:48 PM View: | Akebia Therapeutics, Inc. (AKBA) | 29-Feb-24 | Sale | 5,974 | $1.58 | $9,438.92 | (< 1%) 669.23K to 663.26K | |
| 29-Feb-24 6:03 PM View: | Akebia Therapeutics, Inc. (AKBA) | 27-Feb-24 | Sale (Planned) | 7,411 | $1.52 | $11,264.70 | (1%) 676.64K to 669.23K | |
| 02-Feb-24 4:10 PM View: | Akebia Therapeutics, Inc. (AKBA) | 31-Jan-24 | Grant | 149,300 | -- | -- | 28% 527.34K to 676.64K | |
| 25-May-23 9:01 PM View: | Akebia Therapeutics, Inc. (AKBA) | 25-May-23 | Sale | 63,186 | $1.22 | $77,270.20 | (11%) 587.53K to 524.34K | |
| 25-May-23 9:01 PM View: | Akebia Therapeutics, Inc. (AKBA) | 24-May-23 | Grant | 200,000 | -- | -- | 52% 387.53K to 587.53K | |
| 16-May-23 4:10 PM View: | Akebia Therapeutics, Inc. (AKBA) | 12-May-23 | Grant | 100,000 | -- | -- | 35% 287.53K to 387.53K | |
| 03-Mar-23 8:01 AM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Mar-23 | Sale | 13,034 | $0.88 | $11,437.30 | (4%) 300.56K to 287.53K | |
| 01-Mar-23 4:05 PM View: | Akebia Therapeutics, Inc. (AKBA) | 27-Feb-23 | Sale | 6,677 | $0.81 | $5,429.74 | (2%) 307.24K to 300.56K | |
| 02-Mar-22 9:10 PM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Mar-22 | Sale | 14,507 | $2.17 | $31,490.30 | (5%) 318.75K to 304.24K | |
| 02-Mar-22 9:10 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-22 | Grant | 50,000 | -- | -- | 18% 272.3K to 322.3K | |
| 02-Mar-22 9:10 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-22 | Sale | 6,555 | $2.15 | $14,124.70 | (2%) 322.3K to 315.75K | |
| 01-Apr-21 8:33 PM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Apr-21 | Market Sale | 1,060 | $3.40 | $3,604.00 | (< 1%) 273.36K to 272.3K | < 1% |
| 18-Mar-21 7:18 PM View: | Akebia Therapeutics, Inc. (AKBA) | 16-Mar-21 | Grant | 10,192 | -- | -- | 4% 263.17K to 273.36K | |
| 02-Mar-21 4:08 PM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Mar-21 | Market Sale | 14,285 | $3.40 | $48,513.30 | (5%) 277.46K to 263.17K | |
| 02-Mar-21 4:08 PM View: | Akebia Therapeutics, Inc. (AKBA) | 26-Feb-21 | Grant | 62,000 | -- | -- | 29% 215.46K to 277.46K | |
| 02-Mar-20 7:28 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-20 | Grant | 62,000 | -- | -- | 39% 157.81K to 219.81K | |
| 02-Mar-20 7:28 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-20 | Market Sale | 7,050 | $8.70 | $61,335.00 | (3%) 219.81K to 212.76K | 65% |
| 12-Apr-19 4:00 PM View: | Akebia Therapeutics, Inc. (AKBA) | 11-Apr-19 | Disposition | 11,929 | $7.70 | $91,853.30 | (7%) 166.74K to 154.81K | 61% |
| 05-Mar-19 10:00 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-19 | Grant | 65,000 | -- | -- | 64% 101.73K to 166.74K | |
| 13-Dec-18 8:15 AM View: | Akebia Therapeutics, Inc. (AKBA) | 12-Dec-18 | Payment of Exercise | 20,175 | $8.94 | $180,364.00 | (17%) 121.46K to 101.28K | 66% |
| 02-Mar-18 4:15 PM View: | Akebia Therapeutics, Inc. (AKBA) | 28-Feb-18 | Grant | 17,500 | -- | -- | 17% 102.58K to 120.08K | |
| 04-Oct-17 4:21 PM View: | Akebia Therapeutics, Inc. (AKBA) | 02-Oct-17 | Market Sale (Planned) | 7,803 | $19.89 | $155,188.00 | (7%) 109.61K to 101.8K | 85% |
| 06-Jul-17 12:24 PM View: | Akebia Therapeutics, Inc. (AKBA) | 03-Jul-17 | Market Sale | 1,554 | $14.26 | $22,156.50 | (1%) 111.16K to 109.61K | 79% |
| 04-Apr-17 4:01 PM View: | Akebia Therapeutics, Inc. (AKBA) | 03-Apr-17 | Market Sale | 1,556 | $9.18 | $14,280.20 | (1%) 111.41K to 109.86K | 67% |
| 23-Feb-17 4:02 PM View: | Akebia Therapeutics, Inc. (AKBA) | 21-Feb-17 | Grant | 28,500 | -- | -- | 34% 82.91K to 111.41K | |
| 03-Jan-17 4:01 PM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Jan-17 | Market Sale | 1,810 | $10.49 | $18,988.00 | (2%) 84.72K to 82.91K | 71% |
| 04-Oct-16 4:12 PM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Oct-16 | Market Sale | 1,556 | $8.95 | $13,933.70 | (2%) 85.47K to 83.92K | 68% |
| 06-Jul-16 4:08 PM View: | Akebia Therapeutics, Inc. (AKBA) | 05-Jul-16 | Market Sale | 1,557 | $7.47 | $11,625.30 | (2%) 87.03K to 85.47K | 62% |
| 05-Apr-16 4:03 PM View: | Akebia Therapeutics, Inc. (AKBA) | 04-Apr-16 | Market Sale | 1,556 | $9.41 | $14,642.00 | (2%) 87.08K to 85.53K | 70% |
| 24-Feb-16 4:06 PM View: | Akebia Therapeutics, Inc. (AKBA) | 22-Feb-16 | Grant | 22,500 | -- | -- | 35% 64.58K to 87.08K | |
| 06-Jan-16 4:04 PM View: | Akebia Therapeutics, Inc. (AKBA) | 04-Jan-16 | Market Sale | 1,811 | $12.28 | $22,239.10 | (3%) 66.39K to 64.58K | 77% |
| 05-Oct-15 4:02 PM View: | Akebia Therapeutics, Inc. (AKBA) | 02-Oct-15 | Market Sale (Planned) | 1,484 | $8.67 | $12,859.90 | (2%) 66.74K to 65.26K | 67% |
| 06-Jul-15 4:03 PM View: | Akebia Therapeutics, Inc. (AKBA) | 02-Jul-15 | Market Sale (Planned) | 1,484 | $9.54 | $14,160.50 | (2%) 68.23K to 66.74K | 70% |
| 06-Apr-15 4:13 PM View: | Akebia Therapeutics, Inc. (AKBA) | 02-Apr-15 | Market Sale (Planned) | 1,483 | $9.09 | $13,477.70 | (2%) 77.58K to 76.09K | 69% |
| 06-Apr-15 4:13 PM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Apr-15 | Grant | 4,539 | $9.51 | $43,165.90 | 6% 73.04K to 77.58K | (70%) |
| 05-Jan-15 4:35 PM View: | Akebia Therapeutics, Inc. (AKBA) | 02-Jan-15 | Market Sale (Planned) | 1,715 | $11.46 | $19,655.10 | (2%) 74.75K to 73.04K | 75% |
| 05-Jan-15 4:35 PM View: | Akebia Therapeutics, Inc. (AKBA) | 01-Jan-15 | Grant | 4,539 | $11.64 | $52,834.00 | 6% 70.21K to 74.75K | (76%) |
| 03-Dec-14 4:07 PM View: | Akebia Therapeutics, Inc. (AKBA) | 02-Dec-14 | Payment of Exercise | 5,910 | $11.43 | $67,551.30 | (8%) 76.12K to 70.21K | 75% |
| 27-Mar-14 4:00 PM View: | Akebia Therapeutics, Inc. (AKBA) | 25-Mar-14 | Purchase | 3,500 | $17.00 | $59,500.00 | 5% 72.62K to 76.12K |